Unknown

Dataset Information

0

The Ubiquitin-Specific Protease 18 Promotes Hepatitis C Virus Production by Increasing Viral Infectivity.


ABSTRACT: Background and Aims:Ubiquitin-specific protease 18 (USP18) is involved in immunoregulation and response to interferon- (IFN-) based treatment in patients chronically infected with hepatitis C virus (HCV). We investigated whether and how its upregulation alters HCV infection. Methods:Overexpression of wild-type (USP18 WT) or catalytically inactive mutant (USP18 C64S) USP18 was examined for effects on HCV replication in the absence and presence of IFN? or IFN? using both the HCV-infective model and replicon cells. The IFN signaling pathway was assessed via STAT1 phosphorylation (western blot) and downstream ISG expression (real-time PCR). Mechanistic roles were sought by quantifying microRNA-122 levels and J6/JFH1 infectivity of Huh7.5 cells. Results:We found that overexpression of either USP18 WT or USP18 C64S stimulated HCV production and blunted the anti-HCV effect of IFN? and IFN? in the infective model but not in the replicon system. Overexpressed USP18 showed no effect on Jak/STAT signaling nor on microRNA-122 expression. However, USP18 upregulation markedly increased J6/JFH1 infectivity and promoted the expression of the key HCV entry factor CD81 on Huh7.5 cells. Conclusions:USP18 stimulates HCV production and blunts the effect of both type I and III IFNs by fostering a cellular environment characterized by upregulation of CD81, promoting virus entry and infectivity.

SUBMITTER: Li Y 

PROVIDER: S-EPMC6906844 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Ubiquitin-Specific Protease 18 Promotes Hepatitis C Virus Production by Increasing Viral Infectivity.

Li Yujia Y   Ma Max Xuezhong MX   Qin Bo B   Lin Liang-Tzung LT   Richardson Christopher D CD   Feld Jordan J   McGilvray Ian D ID   Chen Limin L  

Mediators of inflammation 20191118


<h4>Background and aims</h4>Ubiquitin-specific protease 18 (USP18) is involved in immunoregulation and response to interferon- (IFN-) based treatment in patients chronically infected with hepatitis C virus (HCV). We investigated whether and how its upregulation alters HCV infection.<h4>Methods</h4>Overexpression of wild-type (USP18 WT) or catalytically inactive mutant (USP18 C64S) USP18 was examined for effects on HCV replication in the absence and presence of IFN<i>α</i> or IFN<i>λ</i> using bo  ...[more]

Similar Datasets

| S-EPMC10797686 | biostudies-literature
| S-EPMC3791519 | biostudies-literature
2015-04-20 | E-GEOD-61501 | biostudies-arrayexpress
2015-04-20 | GSE61501 | GEO
| S-EPMC3794584 | biostudies-literature
| S-EPMC3545798 | biostudies-other
| S-EPMC10823351 | biostudies-literature
| S-EPMC6159995 | biostudies-literature
| S-EPMC4886784 | biostudies-literature
| S-EPMC6224254 | biostudies-literature